Pharmaceutical Excipients Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmaceutical Excipients Market 

5.1. COVID-19 Landscape: Pharmaceutical Excipients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmaceutical Excipients Market, By Product

8.1. Pharmaceutical Excipients Market, by Product, 2022-2030

8.1.1. Organic Chemicals

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Inorganic Chemicals

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Pharmaceutical Excipients Market, By Functionality

9.1. Pharmaceutical Excipients Market, by Functionality, 2022-2030

9.1.1. Fillers and Diluents

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Suspending and Viscosity Agents

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Coating Agents

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Binders

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Disintegrants

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Colorants

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Lubricants and Glidants

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Preservatives

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Emulsifying Agents

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Flavoring Agents and Sweeteners

9.1.10.1. Market Revenue and Forecast (2017-2030)

9.1.11. Other Functionalities

9.1.11.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Pharmaceutical Excipients Market, By Formulations 

10.1. Pharmaceutical Excipients Market, by Formulations, 2022-2030

10.1.1. Topical Formulations

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Oral Formulations

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Parenteral Formulations

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.3. Other Formulations

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Pharmaceutical Excipients Market, By End-Users

11.1. Pharmaceutical Excipients Market, by End-Users, 2022-2030

11.1.1. Pharmaceuticals Companies

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Research Organization

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Academics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Other

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Pharmaceutical Excipients Market, By Distribution Channel

12.1. Pharmaceutical Excipients Market, by Distribution Channel, 2022-2030

12.1.1. Online Pharmacy

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Retail

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Mail-Order

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Pharmaceutical Excipients Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.1.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.1.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.1.7. Market Revenue and Forecast, by Distribution Channel (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.1.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.1.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.4. Market Revenue and Forecast, by End-Users (2017-2030) 

13.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.7. Market Revenue and Forecast, by End-Users (2017-2030) 

13.2.8. Market Revenue and Forecast, by Distribution Channel (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.10. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.12.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.2.14.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.2.15. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.10.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.3.11.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.10.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.4.11.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.5.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.5.6.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Formulations (2017-2030)

13.5.8.4. Market Revenue and Forecast, by End-Users (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)

Chapter 14. Company Profiles

14.1. Ashland Global Holdings

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. BASF SE

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. DuPont

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Roquette Feres

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Evonik Industries AG

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Associated British Foods

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Archer Daniels Midland Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Lubrizol Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Croda International

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Kerry Group

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms